CAH: Cardinal Health, Inc. Stock

by  •  • Comments Off on CAH: Cardinal Health, Inc. Stock

SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries

Valuation
Market Cap ($M) 25,184.36
Enterprise Value ($M) 25,318.36
Book Value ($M) -3,447.00
Book Value / Share -14.17
Price / Book -7.31
NCAV ($M) -12,362.00
NCAV / Share -50.82
Price / NCAV -2.04

Profitability (mra)
Return on Invested Capital (ROIC) 0.50
Return on Assets (ROA) 0.01
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.50
Current Ratio 0.98

Balance Sheet (mrq) ($M)
Current Assets 37,658.00
Assets 46,573.00
Liabilities 50,020.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 12.69 -0.17
01-30 13G/A State Street Corp 5.90 -17.24
01-24 13G/A BlackRock Inc. 10.60 -11.56

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 1
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 330,863 1,356,150 24.40
2024-04-24 285,232 2,057,344 13.86
2024-04-23 498,259 2,477,426 20.11
2024-04-22 1,594,849 5,287,253 30.16

(click for more detail)

Similar Companies
HLF – Herbalife Ltd. MCK – McKesson Corporation
NUS – Nu Skin Enterprises, Inc.


Financial data and stock pages provided by
Fintel.io